BACKGROUND: Brazil requires the performance of both a test for hepatitis B surface antigen (HBsAg) and a test for antibodies to the core of hepatitis B for blood donor screening. Blood centres in regions of high HBV endemicity struggle to maintain adequate stocks in face of the high discard rates due to anti-HBc reactivity. We evaluated the potential infectivity of donations positive for anti-HBc in search of a rational approach for the handling of these collections. STUDY DESIGN AND METHODS: We tested anti-HBc reactive blood donations from the state of Amazonas for the presence of HBV DNA and for titres of anti-HBs. The study population consists of village-based donors from the interior of Amazonas state. RESULTS: Among 3600 donations, 799 were anti-HBc reactive (22·2%). We were able to perform real-time PCR for the HBV S gene on specimens from 291 of these donors. Eight of these samples were negative for HBsAg and positive for HBV DNA and were defined as occult B virus infections (2·7%). Six of those eight specimens had anti-HBs titres above 100 mIU/ml, indicating the concomitant presence of the virus with high antibody titres. CONCLUSION: A small proportion of anti-HBc reactive donors carry HBV DNA and anti-HBs testing is not useful for predicting viremia on them. This finding indicates the possibility of HBV transmission from asymptomatic donors, especially in areas of high HBV prevalence. Sensitive HBV DNA nucleic acid testing may provide another level of safety, allowing eventual use of anti-HBc reactive units in critical situations.
BACKGROUND: Brazil requires the performance of both a test for hepatitis B surface antigen (HBsAg) and a test for antibodies to the core of hepatitis B for blood donor screening. Blood centres in regions of high HBV endemicity struggle to maintain adequate stocks in face of the high discard rates due to anti-HBc reactivity. We evaluated the potential infectivity of donations positive for anti-HBc in search of a rational approach for the handling of these collections. STUDY DESIGN AND METHODS: We tested anti-HBc reactive blood donations from the state of Amazonas for the presence of HBV DNA and for titres of anti-HBs. The study population consists of village-based donors from the interior of Amazonas state. RESULTS: Among 3600 donations, 799 were anti-HBc reactive (22·2%). We were able to perform real-time PCR for the HBV S gene on specimens from 291 of these donors. Eight of these samples were negative for HBsAg and positive for HBV DNA and were defined as occult B virus infections (2·7%). Six of those eight specimens had anti-HBs titres above 100 mIU/ml, indicating the concomitant presence of the virus with high antibody titres. CONCLUSION: A small proportion of anti-HBc reactive donors carry HBV DNA and anti-HBs testing is not useful for predicting viremia on them. This finding indicates the possibility of HBV transmission from asymptomatic donors, especially in areas of high HBV prevalence. Sensitive HBV DNA nucleic acid testing may provide another level of safety, allowing eventual use of anti-HBc reactive units in critical situations.
Authors: Dennis Armando Bertolini; Michele Soares Gomes-Gouvêa; Isabel Maria Vicente Guedes de Carvalho-Mello; Isabel Maria Vicente Guedes de Carvalho-Mello; Cláudia Patara Saraceni; Roberta Sitnik; Felipe Gobbi Grazziotin; Jomar Pereira Laurino; Jomar Pereira Laurindo; Nelson Jurandi Rosa Fagundes; Flair José Carrilho; João Renato Rebello Pinho Journal: Infect Genet Evol Date: 2012-04-17 Impact factor: 3.342
Authors: M Devesa; C L Loureiro; Y Rivas; F Monsalve; N Cardona; M C Duarte; F Poblete; M F Gutierrez; C Botto; F H Pujol Journal: J Med Virol Date: 2008-01 Impact factor: 2.327
Authors: Wornei Silva Miranda Braga; Márcia da Costa Castilho; Fabiane Giovanella Borges; Ana Cristina de Souza Martinho; Ivo Seixas Rodrigues; Eliete Pereira de Azevedo; Márcia Scazufca; Paulo Rossi Menezes Journal: Rev Soc Bras Med Trop Date: 2012-02 Impact factor: 1.581
Authors: Wornei Silva Miranda Braga; Eva Batista da Silva; Rita Auxiliadora Botelho de Souza; Carlos Eduardo Tosta Journal: Rev Soc Bras Med Trop Date: 2005-05-04 Impact factor: 1.581
Authors: A-R El-Zayadi; E H Ibrahim; H M Badran; A Saeid; N A Moneib; M A Shemis; R M Abdel-Sattar; A M Ahmady; A El-Nakeeb Journal: Transfus Med Date: 2008-02 Impact factor: 2.019
Authors: Marion Vermeulen; Nico Lelie; Wendy Sykes; Robert Crookes; Johanna Swanevelder; Lilian Gaggia; Martin Le Roux; Eben Kuun; Sam Gulube; Ravi Reddy Journal: Transfusion Date: 2009-02-27 Impact factor: 3.157
Authors: Ricardo Wagner de Almeida; Francisco Campello do Amaral Mello; Isabelle Vasconcelos Menegoy; Márcia Paschoal do Espírito Santo; Cléber Ferreira Ginuíno; Paulo Sérgio Fonseca de Sousa; Livia Melo Villar; Elisabeth Lampe; Lia Laura Lewis-Ximenez Journal: Mem Inst Oswaldo Cruz Date: 2017-07 Impact factor: 2.743